Cargando…
New Advances in Targeted Therapy of HER2-Negative Breast Cancer
Breast cancer has an extremely high incidence in women, and its morbidity and mortality rank first among female tumors. With the increasing development of molecular biology and genomics, molecular targeted therapy has become one of the most active areas in breast cancer treatment research and has al...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931202/ https://www.ncbi.nlm.nih.gov/pubmed/35311116 http://dx.doi.org/10.3389/fonc.2022.828438 |